NVCT

$9.71+0.82 (+9.22%)

Pre-Market$9.10-0.61 (-6.28%)· Last close May 5

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO